Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?

about

Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?

Item

http://www.wikidata.org/entity/Q35925719

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Hyperhomocysteinemia and the r ...... ery stenting: fact or fiction?

@ast

Hyperhomocysteinemia and the r ...... ery stenting: fact or fiction?

@en

type

Item

label

Hyperhomocysteinemia and the r ...... ery stenting: fact or fiction?

@ast

Hyperhomocysteinemia and the r ...... ery stenting: fact or fiction?

@en

prefLabel

Hyperhomocysteinemia and the r ...... ery stenting: fact or fiction?

@ast

Hyperhomocysteinemia and the r ...... ery stenting: fact or fiction?

@en

P1476

Hyperhomocysteinemia and the r ...... ery stenting: fact or fiction?

@en

P2093

Reza Tabrizchi

http://www.w3.org/2001/XMLSchema#string

P2860

Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS)

Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS

Homocysteine: a new cardiac risk factor?

Sirolimus-eluting coronary stents: novel devices for the management of coronary artery disease.

Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting.

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.

Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis.

The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation Study.

Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries.

Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.

P304

935-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2.6.935

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15500438

http://www.w3.org/2001/XMLSchema#string